Mostrando 2 resultados de: 2
Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6 and CYP2C19 genotypes and dosing of selective serotonin reuptake inhibitors
ArticleAbstract: Selective serotonin reuptake inhibitors (SSRIs) are primary treatment options for major depressive aPalabras claves:Autores:Adrián LLerena, Bishop J.R., Caudle K.E., Chiulli D.L., Gaedigk A., Graham R.L., Hicks J.K., Ji Y., Klein T.E., Leckband S.G., Leeder J.S., Muller D.J., Sangkuhl K., Scott S.A., Skaar T.C., Stingl J.C.Fuentes:scopusThe Sixth European Society of Pharmacogenomics and Personalised Therapy Congress
Conference ObjectAbstract: On 8-9 November 2022, the European Society of Pharmacogenomics and Personalised Therapy organized itPalabras claves:Autores:Adrián LLerena, Akin D., Ansari M., Bozina N., Christrup L., Daly A.K., Florindi F., Henricks L.M., Ingelman-Sundberg M., Manolopoulos V.G., Molden E., Morris T., Muller D.J., Niemi M., Patrinos G.P., Pavlovic S., Primorac D., Russmann S., Sipeky C., Stanković S., Swen J.J., Van Den Broek W., Van Schaik R.H.N., Zukic B.Fuentes:scopus